Alex Kim
Appearances
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY - DateMay 21, 2024Objectives: Neoadjuvant therapy (NT) is increasingly utilized prior to surgery for most gastrointestinal (GI) and hepatopancreatobiliary (HPB) malignancies. However, chemotherapy and radiation therapy can cause significant symptoms and a high incidence of adverse events…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY